Fri, Jan 30, 2015, 1:37 AM EST - U.S. Markets open in 7 hrs 53 mins

Recent

% | $
Quotes you view appear here for quick access.

Protalix BioTherapeutics, Inc. (PLX) Message Board

jagan1961 720 posts  |  Last Activity: 5 hours ago Member since: Oct 31, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • These Crooks (shorts) have spies all over the place, they will know the results first then only the management.

    If they know where this trials being held they will go to any extent to sniff out the results.

    Nothing is secret to these crooks.

    GLTA LONGS!

    Sentiment: Strong Buy

  • Reply to

    Earnings Conference Call

    by thousandhills1 6 hours ago
    jagan1961 jagan1961 6 hours ago Flag

    Earnings is supposed to be on 02/04.

    So long as there is no Adverse events reported we can assume things are going very smooth.

    I do definitely expect some positive responses with these Open Label trials as well as the 3 MG PH 2A results along with the PH2 B 2mg FDA hold issue.

    GL!

    Sentiment: Strong Buy

  • Reply to

    ARWR single dose study

    by teberb 7 hours ago
    jagan1961 jagan1961 6 hours ago Flag

    hparch: The standard therapy right now for HBV is either one of the 2 Drugs, that means those who are going to be administered ARC-520 are already undergoing treatment under these drugs.

    A 45 day trial, if they started administration for these patients during Dec, that means we will be getting these results soon I presume.

    JMHO,I expect a FC result with these 3mg / 4 mg single dose.

    GL!

    Sentiment: Strong Buy

  • This is what I'm thinking of. If they come and mentions something, there are so ambulance chasing lawyers.

    Keep quiet and sign the buyout. Everything points towards a buyout from Baxter, including paying off the loan.

    GL!

    Sentiment: Strong Buy

  • Given the short activism for the past 2/3 days after approval and the earlier shorted shares we have a minimum of 15-16 million shares needs cover.

    let us see how these guys manipulate further, after 2 drug approvals with almost 70-80 mln cash and a possible Baxter buyout.

    Every big pharma needs approved Drugs to sell, RMTI is well placed for a takeover.

    GL!

    Sentiment: Strong Buy

  • Reply to

    It just hit me...

    by mudbug021 Jan 29, 2015 12:30 AM
    jagan1961 jagan1961 15 hours ago Flag

    attack_sub: What mudbug is bringing is just rehashing the same stuff. It is not a genuine concern here, because as of this date, Pegasys interferon is the standard therapy and we all know how it works.

    ARC-520 prevention and Cure, the existing drugs only kills the Virus and DO NOT STOP its production. The human body needs to attain immune system with the existing drugs it takes ages to get the Cure and very few gets FC even after 100's of dosages of the Drug.

    Horrible side effects too.

    GLTA LONGS!

    Sentiment: Strong Buy

  • They are uneasy right now, with the Blow out baxter results and every pharma is looking for Approved Drugs in its portfolio!

    Baxter will take them out for 20-22$ per share.

    GL!

    Sentiment: Strong Buy

  • Unsure why the market is punishing this much. They are safe till end of 2015 and by which time the Oil is expected to go back to $80 per barrel.

    Big boyz will be on the prowl to acquire the assets of Small players like GDP, where they will get contiguous acreages for overall cost reduction along with infrastructure development.

    40000 odd acres at Texas will fetch them a decent price and they can leverage just the TMS once the dust settles where their operations cost less than 45-50 $ per barrel break-even.

    GL!

    Sentiment: Strong Buy

  • The poster ARC 520 posted many times that he is one of those who takes this Drug.

    They need to take 200-300 dosages before they reach FC and it is very expensive, most of them won't get FC, that is where ARC 520 comes to play.

    Even those who are on ARC 520 PH 2 A, are in fact taking this drug and in combination or a standalone ARC 520 does not cause any AE and works very well, complementing the existing Drugs.

    GLTA LONGS!

    Sentiment: Strong Buy

  • Looks to me a sure shot winner here. With 20-22 $ per share, they can takeover RMTI with 2 approved Drugs, very cheap valuation to add to their portfolio!

    Why pay Royalties?

    On top of it they have close to 200 MLN in Tax loss, which is worth another 70 MLN $.

    GL!

    Sentiment: Strong Buy

  • Reply to

    It just hit me...

    by mudbug021 Jan 29, 2015 12:30 AM
    jagan1961 jagan1961 18 hours ago Flag

    mudbug: this was already stated, I don't know what is new here.

    This pegasys is used to treat the existing HBV and then ARC-520 will suppress the viral production, thereby reaching Functional cure.

    It was always an option with them. Even those patients in PH 2 A have been taking this Drug, since they can't stop taking it.

    Nothing unusual here, it is stated earlier and this is the perfect logical step.

    ARC-520 don't cure already existing HBV in the system, you need this Drug.

    GLTA LONGS!

    Sentiment: Strong Buy

  • Later it went back, seems to be something in the works.

    The Texas Shale play - producing property of 44000 Acres can be sold easily to potential buyers since CRZO, EOG are all having adjacent fields. Even if they sell at Cost basis, they will be able to retire substantial amount of Debt and just focus on the TS play, where they can consolidate all their operations.

    They spent close to 300-400 Mln $ on TS play, it will be the only viable asset, hopefully a low cost play.

    GL!

    Sentiment: Hold

  • Reply to

    RMTI up to day's high on huge volume...........

    by sparty_one Jan 27, 2015 11:23 AM
    jagan1961 jagan1961 Jan 27, 2015 11:28 AM Flag

    Volume is low. No one is selling here. 9+ Mln share volume yesterday.

    Sentiment: Hold

  • Till such time they load up the stock won't retrace. If you sell now I doubt you can get it back.

    MOMO plays won't work when the institutions are entering in this play. Overall the institutional holding is very low here.

    GL!

    Sentiment: Hold

  • Reply to

    14-15 MLN shares to cover!

    by jagan1961 Jan 27, 2015 9:54 AM
    jagan1961 jagan1961 Jan 27, 2015 9:56 AM Flag

    Funny part is the institutions are owning the stock. They will lend the shares only to make more profit.

    Shorts are in a NO WIN Situation.

    GLTA LONGS!

    Sentiment: Strong Buy

  • If you have options just put it at least 2-3 $ above the current Price.

    Stock might surpass $12 easy here.

    GLTA LONGS!

    Sentiment: Strong Buy

  • Reply to

    End??

    by pt117cool Jan 26, 2015 11:32 PM
    jagan1961 jagan1961 Jan 27, 2015 8:35 AM Flag

    Things are going to be tough for the shorts now. Next stop is $12.

    GLTA LONGS!

    Sentiment: Strong Buy

  • Rockwell Medical (RMTI) Price Target Raised at Oppenheimer Amid Triferic Approval, Label In-Line with Expectations
    7:09 AM ET, 01/27/2015 - StreetInsider

    Oppenheimer analyst Ling Wang reiterated an Outperform rating and boosted the price target on Rockwell Medical Technologies (NASDAQ: RMTI) to $26.00 (from $24.00) following FDA approval for Triferic. Wang said the label is in line with their expectations.
    Wang commented, "On 1/26, the FDA approved Triferic for the replacement of iron to maintain hemoglobin (Hg) in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD). Triferic is the only approved therapy for this indication. The label is in line with our expectation. With a proven clinical benefit to effectively deliver iron and maintain Hg without increasing iron store, potentially significant cost savings for dialysis centers, a highly concentrated client base and strong commercialization expertise, we expect Triferic to quickly gain significant market share from IV iron, which was approved for only iron repletion but is currently being used for iron replacement/maintenance therapy.
    For an analyst ratings summary and ratings history on Rockwell Medical Technologies click here. For more ratings news on Rockwell Medical Technologies click here.
    Shares of Rockwell Medical Technologies closed at $10.73 yesterday.

    Sentiment: Hold

  • Reply to

    End??

    by pt117cool Jan 26, 2015 11:32 PM
    jagan1961 jagan1961 Jan 27, 2015 8:07 AM Flag

    Normally what is officially known is "Known Shorts" and there is another called "Phantom Shorts" these are imaginary shares the Short Hedgies Create.

    You can do all sort of manipulation in the Stock market, "If you know how to do it".

    Overall the Stock market is NOT A FAIR MAN's GAME! It is crooked and helps these crooks big time!

    There are more people lose in stock market than making a gain. You need to have steel balz to be staying the market.

    GLTA LONGS!

    Sentiment: Strong Buy

  • Reply to

    Why the Crash in SH price today in my opinion

    by rmtilong Jan 26, 2015 2:45 PM
    jagan1961 jagan1961 Jan 26, 2015 2:50 PM Flag

    They don't wait that long. Generally before the placement itself they will short and buy this in placement and give it back. They won't keep the share for even 1 day.

    In fact the share was over 10 for long, why would these creatures take the risk? They won't.

    Sentiment: Hold

PLX
2.02-0.03(-1.46%)Jan 29 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Core Laboratories NV
NYSEThu, Jan 29, 2015 4:00 PM EST
Facebook, Inc.
NASDAQThu, Jan 29, 2015 4:00 PM EST